Marrone Bio Innovations (MBII) Osake Kurssi

Marrone Bio Innovations Kurssi

NASDAQ·SULJETTU
0
​
Markkina suljettu

Liikevaihto on kasvanut 25,3 % vuodessa viimeisten 11 vuoden aikana 44,31 M USD:een. Marrone Bio Innovationsn nettomarginaali on nyt −37,4 %, noussut −170,2 %:sta muutama vuosi sitten.

Marrone Bio Innovations osakekurssi

Hae nämä tiedot Eulerpool API:n kautta

Marrone Bio Innovations liiketoimintamalli ja osakeanalyysi

Marrone Bio Innovations Inc on yhdysvaltalainen yritys, joka on toiminut biologisen tuholäiskontrollin alalla vuodesta 2006 lähtien. Yrityksen perusti kemisti Dr. Pamela Marrone, ja sen pääkonttori sijaitsee Davisissa, Kaliforniassa. Yrityksen liiketoimintamalli perustuu turvallisten ja tehokkaiden luonnon raaka-aineista valmistettujen biologisten tuholäiskontrollituotteiden kehittämiseen. Tavoitteena on minimoida maatalouden ympäristövaikutukset. Yritys jakautuu eri toimialoihin, kuten biologinen kasvinsuojelu, biologinen typen sidonta, biologinen rikkakasvien torjunta ja muut tuotteet. Tunnetuimpia tuotteita ovat Regalia®, Venerate® ja Majestene®. Marrone Bio Innovations on viime vuosina saavuttanut merkittävyyttä ja on nyt yksi johtavista yrityksistä biologisen tuholäiskontrollin alalla. Yritys tekee tiivistä yhteistyötä viljelijöiden, tutkimuslaitosten ja sääntelyviranomaisten kanssa kehittääkseen ja lanseeratakseen uusia tuotteita, asettaen aina etusijalle turvallisuuden ja ympäristöystävällisyyden.

Usein kysytyt kysymykset Marrone Bio Innovations -osakkeesta

The business model of Marrone Bio Innovations Inc is focused on providing sustainable and environmentally friendly solutions for the agriculture and water treatment industries. Marrone Bio Innovations develops and manufactures bio-based products that protect crops from pests and diseases, improve plant health, and enhance water quality. Their products are derived from naturally occurring microorganisms, which provide effective and safe alternatives to traditional chemical-based pesticides. Marrone Bio Innovations' innovative and eco-friendly solutions aim to help farmers increase crop yields while minimizing environmental impacts.

Marrone Bio Innovations Inc is primarily active in the agriculture and biotechnology industries.

The main competitors of Marrone Bio Innovations Inc in the market include Syngenta AG, Bayer AG, BASF SE, and Corteva Agriscience.

Marrone Bio Innovations Inc is an innovative company that focuses on providing sustainable biological solutions for agriculture and water treatment. Founded in 2006, Marrone Bio Innovations has rapidly grown to become a global leader in the development and commercialization of environmentally friendly and effective biopesticides and plant health products. With a mission to improve the quality and quantity of global food and water supply, the company offers a wide range of natural products that help farmers protect their crops against pests, diseases, and weeds. Marrone Bio Innovations continues to revolutionize the agricultural industry with its cutting-edge technologies and commitment to sustainability.

Marrone Bio Innovations Inc has achieved several significant milestones. The company successfully launched numerous innovative and sustainable bio-based products, establishing a strong position in the agricultural industry. Marrone Bio Innovations Inc also expanded its global reach by establishing strategic partnerships and collaborations with key players in the market. Additionally, the company received various recognitions and awards for its contributions to sustainable agriculture and environmental stewardship. Marrone Bio Innovations Inc continues to drive advancements in biopesticides, biofertility products, and other bio-based solutions, aiming to revolutionize the way pest management and crop protection are approached in modern agriculture.

Marrone Bio Innovations Inc is primarily present in the United States, focusing on various regions within the country. With their headquarters in Davis, California, the company operates across different states, including key agricultural areas such as California's Central Valley and the Midwest. Marrone Bio Innovations Inc also has a presence in international markets, particularly in Europe, where they have established partnerships and distribution networks to expand their reach.

Marrone Bio Innovations Inc represents a commitment to sustainable and environmentally friendly solutions in the agricultural industry. The company focuses on developing and commercializing bio-based pest management and plant health products, aiming to improve crop yields while minimizing the use of synthetic chemicals. With a strong dedication to innovation, Marrone Bio Innovations Inc strives to provide effective and safe products that help farmers maintain healthy and profitable crops. The company's corporate philosophy revolves around sustainability, responsibility, and a dedication to creating a more sustainable and resilient agriculture system.

10 analyytikkoa arvioi tällä hetkellä Marrone Bio Innovations-osaketta: 7 suosittaa ostoa, 3 pitoa ja 0 myyntiä.

Marrone Bio Innovations-osake (MBII) on listattuna 1 pörssissä, muun muassa: NASDAQ (MBII).

The company Marrone Bio Innovations Inc is a leading provider of biological solutions for agriculture and horticulture. The company specializes in the development and marketing of biological pesticides and fertilizers used in agriculture and horticulture. Marrone Bio Innovations' business model is based on the development and marketing of biological products that are safe, effective, and environmentally friendly. The company has divided its products into different categories to best meet the needs of its customers. The core areas of Marrone Bio Innovations are plant protection and fertilization. In the field of plant protection, the company offers a wide range of biological pesticides that combat harmful insects, fungi, and diseases that can affect crop yield and quality. Some of the most well-known products include Grandevo®, Regalia®, Venerate®, Majestene®, Stargus®, and Zequanox®. Marrone Bio Innovations also has a strong presence in the field of fertilization. The company offers biological fertilizers that enrich the soil naturally and support plant growth. Optimized nutrient supply is an important factor in increasing crop quality and yield. Some of the most well-known products include Haven®, Haven CX®, Haven SW®, Haven Pure®, Haven Topper®, and Stargus®. Another important area of Marrone Bio Innovations is the development of biological solutions for horticulture, including growth stimulants for use on lawns, biostimulants for use on ornamental plants, and biological pesticides for use in home gardens. Some of the most well-known products include Haven® for lawns and GardenShield® for ornamental plants. Marrone Bio Innovations has expanded its business model with a strong research and development department. The company continuously invests in the development of new biological products that meet the highest standards. It works closely with scientists, universities, and other experts. Overall, Marrone Bio Innovations has developed a business model based on the development and marketing of biological solutions for agriculture and horticulture. By dividing its products into different categories, the company is able to tailor its products to the needs of its customers. Marrone Bio Innovations focuses on quality and research, working closely with experts to meet the highest standards and offer innovative and environmentally friendly products to its customers.

Liikevaihtoa ei voida laskea Marrone Bio Innovations:lle tällä hetkellä.

Voittoa ei voida laskea Marrone Bio Innovations:lle tällä hetkellä.

P/E-suhdetta ei voida laskea Marrone Bio Innovations:lle tällä hetkellä.

P/S-suhdetta ei voida laskea Marrone Bio Innovations:lle tällä hetkellä.

Marrone Bio Innovations:n Eulpool-laatuscore on 3/10.

Marrone Bio Innovations:n ISIN on US57165B1061. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Marrone Bio Innovations:n WKN on A1W30B. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Marrone Bio Innovations:n ticker on MBII. Tämä pörssinoteeraus käytetään Marrone Bio Innovations-osakkeiden kauppaan pörssissä.

Käypä arvoTerminal
148.30 USD
Yliarviointia/AliarviointiaTerminal
Reilusti arvostettu
Toimiala
Kemikaalit
Osakkeiden lukumäärä
Työntekijät
Liikevaihto per työntekijä
305 586,21 USD
Liikevaihdon kasvu Ø 5 vuotta
EBIT-kasvu Ø 5 vuotta
Nettotulon kasvu Ø 5 vuotta
Valuutta
USD
Julkinen listaus
2.8.2013
ISIN
US57165B1061
CUSIP
57165B106
SEDOL
BCFKQV1
Markkina-arvo
145,56 M USDMicro Cap
52 viikon vaihteluväli
PEG-suhde
—
P/E-suhde
P/Ee-suhde 2022
—
P/S-suhde
P/Se-suhde
—
EV/EBIT
—
P/B-suhde
4,91
ROE (oman pääoman tuotto)
ROA (varojen tuotto)
ROCE (pääomakäytön tuotto)
ROIC (sijoitetun pääoman tuotto)
−26,17 %
Viimeksi päivitetty 8.10.2026 klo 17.22

Marrone Bio Innovations Ticker

NASDAQ · MBII

Marrone Bio Innovations FIGI

MBIIUSD:XB · BBG00JRXYM82MBIIUSD:XS · BBG00JRXYMR1MBIIGBP:XS · BBG00KDGG953

Kaikki tunnusluvut ja syvällinen analyysi Marrone Bio Innovations:sta

Meidän osakeanalyysimme Marrone Bio Innovations-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Marrone Bio Innovations:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: